Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it.

Drizou, M

Treating patients with ALK-rearranged non-small-cell lung cancer: mechanisms of resistance and strategies to overcome it. [electronic resource] - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Jun 2017 - 658-666 p. digital

Publication Type: Journal Article; Review

1699-3055

10.1007/s12094-016-1605-y doi


Anaplastic Lymphoma Kinase
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Drug Resistance, Neoplasm--physiology
Gene Rearrangement
Humans
Lung Neoplasms--drug therapy
Protein Kinase Inhibitors--therapeutic use
Receptor Protein-Tyrosine Kinases--genetics